These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687 [TBL] [Abstract][Full Text] [Related]
4. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition. Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888 [TBL] [Abstract][Full Text] [Related]
5. Characterization of intermediate filaments expressed by Ewing tumor cell lines. Dellagi K; Lipinski M; Paulin D; Portier MM; Lenoir GM; Brouet JC Cancer Res; 1987 Feb; 47(4):1170-3. PubMed ID: 2433034 [TBL] [Abstract][Full Text] [Related]
6. The effect of whole-body irradiation of nude mice on the tumor transplantability and control probability of a human soft tissue sarcoma xenograft. Huang P; Taghian A; Allam A; Freeman J; Duffy M; Suit H Radiat Res; 1996 Mar; 145(3):337-42. PubMed ID: 8927702 [TBL] [Abstract][Full Text] [Related]
7. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647 [TBL] [Abstract][Full Text] [Related]
9. Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice. Scotlandi K; Benini S; Nanni P; Lollini PL; Nicoletti G; Landuzzi L; Serra M; Manara MC; Picci P; Baldini N Cancer Res; 1998 Sep; 58(18):4127-31. PubMed ID: 9751624 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II. Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022 [TBL] [Abstract][Full Text] [Related]
11. [Cell cycle and proliferative pool of human tumor strains transplanted into athymic mice]. Revazova ES; Petrova AS Biull Eksp Biol Med; 1981 Sep; 92(9):335-7. PubMed ID: 6271306 [TBL] [Abstract][Full Text] [Related]
12. Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma. Manara MC; Landuzzi L; Nanni P; Nicoletti G; Zambelli D; Lollini PL; Nanni C; Hofmann F; García-Echeverría C; Picci P; Scotlandi K Clin Cancer Res; 2007 Feb; 13(4):1322-30. PubMed ID: 17317844 [TBL] [Abstract][Full Text] [Related]
13. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma. Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of angiogenic factors in Ewing tumor xenografts by the combination of human interferon-alpha or interferon-beta with ifosfamide. Sancéau J; Wietzerbin J Ann N Y Acad Sci; 2004 Dec; 1030():170-8. PubMed ID: 15659795 [TBL] [Abstract][Full Text] [Related]
15. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy. Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866 [TBL] [Abstract][Full Text] [Related]
16. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963 [TBL] [Abstract][Full Text] [Related]
17. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma. Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899 [TBL] [Abstract][Full Text] [Related]
18. Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Apte RS; Mayhew E; Niederkorn JY Invest Ophthalmol Vis Sci; 1997 May; 38(6):1277-82. PubMed ID: 9152248 [TBL] [Abstract][Full Text] [Related]
19. [Stem cells and connective-tissue tumors: Ewing's sarcoma]. Tirode F; Delattre O Ann Pathol; 2008 Nov; 28 Spec No 1(1):S33-4. PubMed ID: 18984293 [No Abstract] [Full Text] [Related]
20. [Cytophotometric study of human strains of chorionepithelioma, melanoma, Ewing's sarcoma and breast cancer that are transplantable to athymic mice. II]. Revazova ES; Petrova AS; Zubrikhina GN; Iudicheva TN Lab Delo; 1981; (11):668-9. PubMed ID: 6170819 [No Abstract] [Full Text] [Related] [Next] [New Search]